Benzimidazoisoquinoline derivatives inhibit glioblastoma cell proliferation through down-regulating Raf/MEK/ERK and PI3K/AKT pathways

BACKGROUND: Recent studies showed that benzimidazoleisoquinolinone derivatives exhibit anticancer activity against human cancer cell lines. The aim of this study is to evaluate the anti-tumor effects and mechanisms of benzimidazoleisoquinolinones in isocitrate dehydrogenase-wildtype subtype of human...

Fuld beskrivelse

Na minha lista:

Bibliografiske detaljer
Udgivet i:	Cancer Cell Int
Main Authors:	Zhang, Ya-Jun, Xu, Zhi-Gang, Li, Shi-Qiang, He, Liu-Jun, Tang, Yan, Chen, Zhong-Zhu, Yang, Dong-Lin
Format:	Artigo
Sprog:	Inglês
Udgivet:	BioMed Central 2018
Fag:	Primary Research
Online adgang:	https://ncbi.nlm.nih.gov/pmc/articles/PMC6022716/ https://ncbi.nlm.nih.gov/pubmed/29988358 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12935-018-0588-x
Tags:	Tilføj Tag Ingen Tags, Vær først til at tagge denne postø!

Benzimidazoisoquinoline derivatives inhibit glioblastoma cell proliferation through down-regulating Raf/MEK/ERK and PI3K/AKT pathways

Lignende værker